Tooth Tissue Engineering is a dynamic and interdisciplinary field within regenerative medicine focused on developing strategies to regenerate damaged or lost dental tissues. This includes the enamel, dentin, pulp, and periodontal ligament, which collectively contribute to the structure and functionality of natural teeth. Stem cells, particularly those derived from dental pulp or other dental tissues, play a pivotal role in tooth tissue engineering. Researchers employ various biomaterials, scaffolds, and growth factors to create a supportive environment for stem cells, guiding their differentiation into specific dental cell types. Advanced tissue engineering techniques aim to replicate the intricate architecture of natural teeth, including the enamel's hard outer layer and the softer dentin and pulp beneath. Biomimetic approaches seek to mimic the natural tooth development process, promoting the sequential formation of dental tissues. Tooth tissue engineering holds immense potential for regenerative dentistry, offering alternatives to traditional restorative procedures and prosthetics. Successful tooth tissue engineering could revolutionize the treatment of dental diseases, injuries, and congenital anomalies, providing patients with biologically generated replacements for their natural teeth. Ongoing research endeavors focus on refining methodologies, addressing challenges, and advancing toward the practical application of tooth tissue engineering in clinical dentistry.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States